Latest Updates

Sentynl Therapeutics appoints myTomorrows as global provider

Read more

Glenmark to launch Leucovorin Calcium 350 mg/vial in December 2025

Read more

Cipla launches Yurpeak (tirzepatide) for obesity and type 2 diabetes management in India

Read more

Pharmacists can be true changemakers in population health

Read more

Servier India secures CDSCO approval for Vorasidenib for Grade 2 IDH-mutant glioma

Read more

USC India Awards honours Kiran Mazumdar-Shaw with Business Management Award

Read more

Zydus Lifesciences signs licensing deal with Formycon

Read more

From compliance to commitment: India Pharma Inc’s safety reckoning

Read more

Pharma sector records higher deal value in November 2025

Read more

Immutep and Dr Reddy’s enter Exclusive Licensing Agreement for Eftilagimod Alfa

Read more